Definium Therapeutics, Inc. SEC filings DFTX

Definium Therapeutics, Inc. has 504 filings in SEC EDGAR's recent list, going back to Jun 8, 2020. Its latest annual report, Form 10-K, was filed on Feb 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Definium Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure, Other events
Sep 14, 2026 Sep 14, 2026
8-K Current report
Other events
Sep 8, 2026 Sep 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 12, 2026 Aug 12, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
8-K Current report
Material agreement, Other events
Jun 24, 2026 Jun 22, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 22, 2026 Jun 22, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2026 Jun 11, 2026
8-K Current report
Other events
May 19, 2026 May 19, 2026
8-K Current report
Other events
May 12, 2026 May 12, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
8-K Current report
Other events
Apr 22, 2026 Apr 22, 2026
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Officer or director change
Jan 29, 2026 Jan 28, 2026
8-K Current report
Results of operations, Bylaw or fiscal year change, Other events
Jan 12, 2026 Jan 9, 2026
8-K Current report
Results of operations, Other events
Nov 6, 2025 Nov 6, 2025
8-K Current report
Material agreement, Other events
Oct 31, 2025 Oct 29, 2025
8-K Current report
Results of operations, Other events
Oct 29, 2025 Oct 29, 2025
8-K Current report
Other events
Sep 4, 2025 Sep 4, 2025
8-K Current report
Results of operations, Other events
Jul 31, 2025 Jul 31, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2025 Jun 16, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
May 27, 2025 May 27, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Apr 21, 2025 Apr 18, 2025
8-K Current report
Other events
Apr 15, 2025 Apr 15, 2025
8-K Current report
Results of operations
Mar 6, 2025 Mar 6, 2025
8-K Current report
Other events
Jan 30, 2025 Jan 30, 2025
8-K Current report
Officer or director change, Other events
Jan 13, 2025 Jan 10, 2025
8-K Current report
Other events
Dec 16, 2024 Dec 16, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Oct 17, 2024 Oct 17, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Material agreement, Results of operations, Other events
Aug 12, 2024 Aug 9, 2024
8-K Current report
Material agreement, Other events
Jun 28, 2024 May 28, 2024
8-K Current report
Other events
Jun 20, 2024 Jun 20, 2024
8-K Current report
Shareholder vote results
Jun 11, 2024 Jun 10, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
8-K Current report
Other events
Apr 1, 2024 Apr 1, 2024
8-K Current report
Material agreement, Unregistered share sale, Other events
Mar 11, 2024 Mar 7, 2024
8-K Current report
Regulation FD disclosure
Mar 7, 2024 Mar 7, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 7, 2024 Mar 7, 2024
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
8-K Current report
Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 14, 2023 Dec 14, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2023 Nov 2, 2023
8-K/A Amended current report
Other events
Sep 15, 2023 Aug 14, 2023
8-K/A Amended current report
Other events
Sep 15, 2023 Aug 14, 2023
8-K Current report
Regulation FD disclosure, Other events
Aug 14, 2023 Aug 14, 2023
8-K Current report
Material agreement, New debt, Unregistered share sale
Aug 14, 2023 Aug 11, 2023
8-K Current report
Results of operations
Aug 3, 2023 Aug 3, 2023
8-K/A Amended current report
Shareholder vote results
Jul 25, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
Jun 27, 2023 Jun 21, 2023
8-K Current report
Regulation FD disclosure
Jun 20, 2023 Jun 20, 2023
8-K Current report
Other events
Jun 16, 2023 Jun 16, 2023
8-K Current report
Other events
Jun 15, 2023 Jun 15, 2023
8-K Current report
Regulation FD disclosure, Other events
May 24, 2023 May 24, 2023
8-K Current report
Results of operations, Other events
May 17, 2023 May 17, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
8-K Current report
Other events
Apr 18, 2023 Apr 18, 2023
8-K Current report
Officer or director change
Apr 18, 2023 Apr 15, 2023
8-K Current report
Regulation FD disclosure, Other events
Apr 14, 2023 Apr 14, 2023
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
8-K Current report
Results of operations
Mar 9, 2023 Mar 9, 2023
8-K Current report
Other events
Jan 9, 2023 Jan 9, 2023
8-K Current report
Results of operations
Nov 10, 2022 Nov 10, 2022
8-K Current report
Material agreement, Other events
Sep 29, 2022 Sep 27, 2022
8-K Current report
Other events
Sep 14, 2022 Sep 13, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 26, 2022 Aug 26, 2022
8-K Current report
Results of operations, Officer or director change
Aug 11, 2022 Aug 11, 2022
8-K Current report
Regulation FD disclosure, Other events
Jul 21, 2022 Jul 21, 2022
8-K Current report
Bylaw or fiscal year change
Jun 30, 2022 Jun 30, 2022
8-K Current report
Listing notice, Shareholder vote results
Jun 2, 2022 May 27, 2022
8-K Current report
Officer or director change
May 23, 2022 May 23, 2022
8-K Current report
Regulation FD disclosure, Other events
May 19, 2022 May 19, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
8-K Current report
Regulation FD disclosure
May 11, 2022 May 11, 2022
8-K Current report
Regulation FD disclosure
Apr 26, 2022 Apr 26, 2022
8-K Current report
Results of operations, Auditor change
Mar 28, 2022 Mar 28, 2022
8-K Current report
Officer or director change
Mar 25, 2022 Mar 24, 2022
8-K Current report
Change to shareholder rights
Feb 23, 2022 Feb 22, 2022
8-K Current report
Other events
Jan 25, 2022 Jan 25, 2022
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 7, 2022 Jan 5, 2022
6-K Current report (foreign issuer) Dec 29, 2021 Dec 29, 2021
6-K Current report (foreign issuer) Dec 21, 2021 Dec 21, 2021
6-K Current report (foreign issuer) Dec 17, 2021 Dec 14, 2021
6-K Current report (foreign issuer) Dec 17, 2021 Dec 17, 2021
6-K Current report (foreign issuer) Dec 17, 2021 Dec 17, 2021
6-K Current report (foreign issuer) Dec 16, 2021 Dec 16, 2021
6-K Current report (foreign issuer) Dec 9, 2021 Dec 9, 2021
6-K Current report (foreign issuer) Dec 7, 2021 Dec 6, 2021
6-K Current report (foreign issuer) Dec 2, 2021 Dec 2, 2021
6-K Current report (foreign issuer) Dec 1, 2021 Dec 1, 2021
6-K Current report (foreign issuer) Nov 30, 2021 Nov 30, 2021
6-K Current report (foreign issuer) Nov 16, 2021 Nov 16, 2021
6-K Current report (foreign issuer) Nov 15, 2021 Nov 15, 2021
6-K Current report (foreign issuer) Nov 12, 2021 Nov 12, 2021
6-K Current report (foreign issuer) Nov 12, 2021 Nov 12, 2021
6-K Current report (foreign issuer) Nov 5, 2021 Nov 5, 2021
6-K Current report (foreign issuer) Oct 26, 2021 Oct 26, 2021
6-K Current report (foreign issuer) Oct 4, 2021 Oct 4, 2021
6-K Current report (foreign issuer) Sep 30, 2021 Sep 30, 2021
6-K Current report (foreign issuer) Sep 2, 2021 Sep 2, 2021
6-K Current report (foreign issuer) Aug 25, 2021 Aug 24, 2021
6-K Current report (foreign issuer) Aug 17, 2021 Aug 17, 2021
6-K Current report (foreign issuer) Aug 13, 2021 Aug 13, 2021
6-K Current report (foreign issuer) Aug 13, 2021 Aug 12, 2021
6-K Current report (foreign issuer) Aug 13, 2021 Aug 12, 2021
6-K Current report (foreign issuer) Aug 12, 2021 Aug 12, 2021
6-K Current report (foreign issuer) Aug 4, 2021 Aug 3, 2021
6-K Current report (foreign issuer) Jul 28, 2021 Jul 28, 2021
6-K Current report (foreign issuer) Jul 13, 2021 Jul 12, 2021
6-K Current report (foreign issuer) Jul 8, 2021 Jul 8, 2021
6-K Current report (foreign issuer) Jun 24, 2021 Jun 23, 2021
6-K Current report (foreign issuer) Jun 21, 2021 Jun 17, 2021
6-K Current report (foreign issuer) Jun 9, 2021 Jun 9, 2021
6-K Current report (foreign issuer) May 28, 2021 May 28, 2021
6-K Current report (foreign issuer) May 28, 2021 May 27, 2021
6-K Current report (foreign issuer) May 26, 2021 May 26, 2021
6-K Current report (foreign issuer) May 25, 2021 May 24, 2021
6-K Current report (foreign issuer) May 20, 2021 May 20, 2021
6-K Current report (foreign issuer) May 19, 2021 May 18, 2021
6-K Current report (foreign issuer) May 18, 2021 May 17, 2021
6-K Current report (foreign issuer) May 14, 2021 May 14, 2021
6-K Current report (foreign issuer) May 13, 2021 May 13, 2021
6-K Current report (foreign issuer) May 6, 2021 May 5, 2021
6-K Current report (foreign issuer) Apr 28, 2021 May 27, 2021
6-K Current report (foreign issuer) Apr 27, 2021 Apr 27, 2021
6-K Current report (foreign issuer) Apr 23, 2021 Apr 23, 2021

Showing 127 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
DFTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1813814
Former names
Mind Medicine (MindMed) Inc. (until Jan 12, 2026)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.